✦ LIBER ✦

A Phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer

✍ Scribed by Fiedler, W. ;Zeller, W. ;Peimann, C. -J. ;Weh, H. -J. ;Hossfeld, D. K.

Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 779 KB
Volume: 69
Category: Article
ISSN: 1432-1440
DOI: 10.1007/bf01666852

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of recombinant tumor ne

A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma

✍ Nancy Kemeny; Barry Childs; William Larchian; Kim Rosado; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

A phase I trial of recombinant gamma int

A phase I trial of recombinant gamma interferon in patients with cancer

✍ Kenneth A. Foon; Stephen A. Sherwin; Paul G. Abrams; Henry C. Stevenson; Pamela 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 461 KB

A phase I-II trial of the combination of

A phase I-II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-γ in patients with metastatic malignant melanoma

✍ Edward T. Creagan; Charles L. Loprinzi; David L. Ahmann; Daniel J. Schaid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

A Southwest Oncology Group phase II tria

A Southwest Oncology Group phase II trial of recombinant tumor necrosis factor in metastatic breast cancer

✍ G. Thomas Budd; Stephanie Green; Laurence H. Baker; Evan P. Hersh; James K. Weic 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

A Southwest oncology group phase ii tria

A Southwest oncology group phase ii trial of recombinant tumor necrosis factor in metastatic breast cancer

✍ Lawrence Helson; G. Thomas Budd 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

Complications of combined radiotherapy a

Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha ± interferon gamma and melphalan in patients with irresectable soft tissue tumors

✍ Vrouenraets, Bart C.; Keus, Ronald B.; Nieweg, Omgo E.; Kroon, Bin B. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Background: Isolated limb perfusion (ilp) with tumor necrosis factor alpha (tnf alpha) +/-interferon gamma (ifn gamma) and melphalan in patients with primarily irresectable soft tissue sarcoma is promising in terms of tumor regression and limb salvage. however, the feasibility of radiotherapy in